Department of Systems and Information Engineering, University of Virginia, Charlottesville, Virginia 22904-4747, USA.
Ann Allergy Asthma Immunol. 2010 Feb;104(2):172-7. doi: 10.1016/j.anai.2009.11.023.
Prefilled epinephrine autoinjectors are sometimes improperly used by patients, caregivers, and physicians. A user-centered design process led to the development of 2 prototype epinephrine autoinjectors (INT01 and INT02) that have a unidirectional perceived injection end, a self-retracting needle, and, with INT02, voice instructions to assist in guiding users through administration.
To compare the usability and patient preference among 4 epinephrine autoinjectors: EpiPen, TwinJect, INT01, and INT02.
A total of 48 participants were divided equally among 3 age groups: 7 to 10, 11 to 15, and 16 to 55 years. In each group, half had prior TwinJect or EpiPen training. In 1-hour sessions, without training, participants performed simulated-use testing under observation for all 4 epinephrine delivery systems. Usability (i.e., the ability to perform the manufacturer's labeled instructions), task completion time, and preferences were assessed and analyzed based on device, age, previous experience, sex, device malfunction, and testing order.
More participants correctly followed all device instructions with INT02 (22 [46%]) than with INT01 (13 [27%]), EpiPen (6 [12%]), or TwinJect (0 [0%]). The difference among devices was significant (P < .01) after adjusting for device malfunctions and age group (the youngest age group [those aged 7-10 years] performed significantly worse than the other 2 groups). Prior experience, sex, and testing order did not significantly affect this measure. The first choice of overall preference was greater (P < .001) for INT02 (35 participants [73%]) vs. INT01 (7 participants [15%]), EpiPen (5 participants [10%]), and TwinJect (1 participant [2%]).
The user-centered device design may have a significant impact on correct epinephrine autoinjector use and patient preference.
预充式肾上腺素自动注射器有时会被患者、护理人员和医生不当使用。一个以用户为中心的设计过程导致了两种原型肾上腺素自动注射器(INT01 和 INT02)的开发,它们具有单向感知注射端、自动缩回的针头,并且 INT02 还具有语音指令,以帮助指导用户进行给药。
比较 4 种肾上腺素自动注射器(EpiPen、TwinJect、INT01 和 INT02)的易用性和患者偏好。
共有 48 名参与者被平均分为 3 个年龄组:7 至 10 岁、11 至 15 岁和 16 至 55 岁。在每个年龄组中,有一半的参与者之前接受过 TwinJect 或 EpiPen 的培训。在 1 小时的课程中,参与者在没有培训的情况下,在观察下对所有 4 种肾上腺素给药系统进行模拟使用测试。根据设备、年龄、先前经验、性别、设备故障和测试顺序评估和分析了易用性(即执行制造商标记说明的能力)、任务完成时间和偏好。
与 INT01(13[27%])、EpiPen(6[12%])或 TwinJect(0[0%])相比,更多的参与者正确地遵循了 INT02(22[46%])的所有设备说明。在调整设备故障和年龄组(年龄最小的年龄组[7-10 岁]的表现明显差于其他 2 个年龄组)后,设备之间的差异具有统计学意义(P<0.01)。先前的经验、性别和测试顺序并没有显著影响这一衡量标准。整体偏好的首选是更大的(P<0.001),INT02(35 名参与者[73%])比 INT01(7 名参与者[15%])、EpiPen(5 名参与者[10%])和 TwinJect(1 名参与者[2%])。
以用户为中心的设备设计可能对正确使用肾上腺素自动注射器和患者偏好产生重大影响。